Navigation Links
Neupro® (Rotigotine) Provided Clinically Relevant Improvements in Health-Related Quality of Life for People with Parkinson's Disease
Date:9/30/2010

line recording, the study compared the effects of rotigotine administered as a slow-release formulation of 0.5 or 5 mg/kg every second day for 6 days and L-DOPA/benserazide administered daily at 10/7.5 mg/kg s.c., for 6 days in 6-OHDA lesioned rats.

Latency to slow wave sleep (SWS) and paradoxical sleep (REM) onset, duration of waking, SWS and REM sleep and the alpha and delta frequency ratio during SWS were analyzed off-line. No effects were seen with low dose rotigotine or with a placebo vehicle. Pulsatile L-DOPA and continuous rotigotine at 5 mg/kg caused an increase in active waking and a decrease in SWS duration. While L-DOPA had no effect on the alpha/delta power ratio, the high dose of continuous rotigotine decreased the alpha/delta ratio towards an increase in delta power during SWS.

Other UCB sponsored presentations at the 2nd World Parkinson CongressFresh insights into the lives of people living with Parkinson's disease, and their differing needs for information and support were reported in analyses sponsored by UCB and presented at the Congress:

  • Lindvall S, Graham L, O'Brien E, Davis U. A Qualitative Assessment of the Educational and Support Needs of People Living with Parkinson's Disease
  • Verhaeghe A. & Elleboudt L. Learning from Online Discussions about Parkinson's Disease Amongst People with Parkinson's and Their Carers
  • Wullner U, Fuchs G, Reketat N, Randerath O, Kassubek J. Pharmacotherapy for Parkinson's Disease — Patients' Priorities

  • Data from a retrospective cohort study, also presented at the Congress, investigated the clinical and health economic impact of gastrointestinal disorders in patients with Parkinson's disease:

  • Richy F, Gunn A, Makaroff L, Gervasoni C, Helmers S. Disorders in Patients with Parkinson's Disease (PD): A Double-Edged Sword

  • For further informationEimear O Brien, Associate Director, Global CNS CommunicationsT +32 2 559 9271, <
    '/>"/>

    SOURCE UCB
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
    2. Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus
    3. Recent Study Demonstrated VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Improvements in Behavior, Inattention, and Math Test Scores from 1.5 Hours up to 13 Hours following Administration in Children with ADHD
    4. Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI
    5. Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study
    6. Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009
    7. Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study
    8. Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study
    9. Study Data Show INTUNIV™ (guanfacine) Extended Release Tablets Co-administered With Stimulants Provided ADHD Symptom Improvement in Children and Adolescents
    10. New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at 52 Weeks
    11. New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/5/2015)... -- Bayer HealthCare announced today that it has contributed ... the American Society of Clinical Oncology (ASCO) to support ... to unlock vast quantities of information about the experiences ... is proud to join ASCO and the Conquer Cancer ... help people whose lives have been affected by cancer," ...
    (Date:3/5/2015)... 5, 2015   AMC Health , the ... for improving the effectiveness and efficiency of healthcare ... Anazagasty and Jared Wilstead have ... President, Strategic Client Development, and Wilstead will serve ... AMC Health,s commitment to accelerating the adoption of ...
    (Date:3/5/2015)... , March 5, 2015 LUNGevity Foundation, ... Food and Drug Administration,s (FDA) approval of Bristol ... and other immunotherapy treatments add another critical new ... the power of a patient,s own immune system ... been approved specifically for patients with squamous cell ...
    Breaking Medicine Technology:Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 3LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3
    ... Pharmaceuticals, Inc. (Nasdaq: CADX ), a ... proprietary product candidates principally for use in the ... present a corporate overview at the following investment ... Stanley Global Healthcare ConferenceDate:  Tuesday, September 14, 2010 ...
    ... 7 UBM TechInsights is pleased to announce it ... Business Development, Medical Devices. In this role Mr. Johnson ... business in the Medical Devices sector. ...   http://www.newscom.com/cgi-bin/prnh/20100907/SF60618 ) Mr. Johnson comes to ...
    Cached Medicine Technology:Cadence Pharmaceuticals to Present at Four Investment Conferences During the Month of September 2010 2UBM TechInsights Expands Presence in the Medical Devices Sector 2
    (Date:3/6/2015)... Texas (PRWEB) March 06, 2015 First ... 7am today. The new facility is located at 13351 W. ... “Our experienced clinical team is ready 24-7 to provide the ... Dr. Grossman, Facility Medical Director of First Choice Emergency Room ... ribbon cutting with the South Metro Denver Chamber of Commerce ...
    (Date:3/6/2015)... March 06, 2015 Truly Nolen, the ... to announce the grand opening of their first independently-owned ... area down to the Fort Mill – Rock Hill, ... February 27th, 2015 at their new location. ... years of collective experience in the pest control industry. ...
    (Date:3/6/2015)... The Gluten-Free Certification Program (GFCP), ... pleased to announce that Dufflet Pastries, the ground-breaking ... their product line of gluten-free treats certified by ... as satisfying as any of their other desserts! ... contains hydrogenated fats or oils, artificial flavours, colours ...
    (Date:3/6/2015)... The producers of Health Briefs TV ... Washington and vicinity. This is a city which is full ... many outdoor activities. It is also a city where healthcare ... hospitals call the city home and provide care from the ... TV program will be broadcast on CBS KLEW-TV during the ...
    (Date:3/6/2015)... San Diego, CA (PRWEB) March 06, 2015 ... study findings continue to be discussed, Ford & Associates ... wake of a January 2015 filed lawsuit: Verduzco v. ... Court, Northern District of California. , “In light ... those who have used Benicar to evaluate and explore ...
    Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Opens New Facility in Littleton, Colorado 2Health News:First Truly Nolen Franchise Opening in North Carolina 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4Health News:The Health Briefs TV Show to Air in Spokane, Washington 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4
    ... who are regularly exposed to moderate to high levels of ... count, according to a study published in the September issue ... with painters and decorators are at highest risk. The only ... low sperm counts and low sperm activity was repeated exposure ...
    ... with smokers have a relatively poor diet, which adds to ... that second-hand smoke accounts for up to 24 per cent ... smoking - usually because they live with a smoker or ... offset some of the negative effects.// ,Researchers at ...
    ... has told the British Psychological Society that people who feel ... of the television, or going shopping are more likely to ... to disease.Those on the other hand who feel little or ... ,Researchers asked 30 students aged 18-30 to list enjoyable ...
    ... Sluggish growth in the first year of a boy's life greatly ... a study of Finnish children. , ,The key factor in heart ... grew in the past. It's long been known that babies with ... heart disease in adulthood as heavier babies.// , ,David Barker, an ...
    ... to feel drunk than non-smoking drinkers – placing them ... hearts, a new study suggests. ,The study shows nicotine ... a good model for humans.Since alcohol abusers generally "drink to ... an expected level of intoxication, say the researchers from the ...
    ... pesticides and solvents can further lower fertility among infertile ... may worsen the effect of pre-existing genetic or medical ... findings should be treated with caution because they involved ... farming region in Austria. But they say the dramatic ...
    Cached Medicine News:
    Lyphochek Hemostasis Control is a multi-analyte control to help monitor coagulation factor assays and selected thrombosis risk assays. Assayed values are available for most major instrumentation....
    ... Liquichek Qualitative Urine Toxicology Control is a ... rapid urine drug screen panels, including Point ... test kits like Bio-Rad TOX/See, Biosite Triage ... qualitative results (+/) for popular kits and ...
    Liquichek Reticulocyte Control is a human whole blood based control designed to monitor manual and automated methods for counting reticulocytes. Assayed values are provided at three clinically signif...
    Liquichek Hematology Control (C) is an assayed hematology control for evaluating the performance of Coulter hematology instruments with complete CBC and VCS 5-part differential technology....
    Medicine Products: